U.S. Preventative Services Task Force cancels meeting to review prostate-cancer screening

NewsGuard 100/100 Score
The Wall Street Journal Health Blog: "The United States Preventive Services Task Force has canceled a meeting set for early next month at which the thorny issue of prostate-cancer screening was due for a vote. ... [W]hen prostate-cancer screening came up last fall, the USPSTF initially voted to recommend against screening for men of all ages before opting instead to re-vote on the issue. … Currently the USPSTF has an 'I' rating for prostate-cancer screening, which means the current evidence is insufficient to assess the balance of benefits and harms, for men younger than 75. For older men, the rating is 'D,' which means the USPSTF recommends against screening. The group last issued recommendations in August 2008, but in 2009, results from two large screening trials were published. The studies provided no clear answer of whether the benefits of screening outweighed the harms" (Hobson, 10/26).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New cancer projections show increased prostate cases by 25% in 2050, despite prevention efforts